Ignite Creation Date:
2024-07-17 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06487546
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-06-27
Brief Title:
Repletion of Ergothioneine in Patients With Kidney Failure
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Repletion of Ergothioneine in Patients With Kidney Failure
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Dialysis removes potentially harmful chemicals from the blood but can also remove potentially valuable chemicals One potentially valuable chemical called ergothioneine which comes from our diet is low in the blood of people receiving dialysis For this research study we hope to learn how well a daily ergothioneine supplement will replenish the levels in the blood of people with kidney failure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None